Therapeutic Drug Monitoring

Home Clinical Laboratory Diagnostic Products and Solutions Chemistry Therapeutic Drug Monitoring

Chemistry

Costly. Deadly. Global.

Lack of therapeutic drug monitoring can lead to higher death rates, more adverse drug reactions and has proven costly to employers.
And the numbers are staggering.

Menu Offering*

Therapeutic Drug Monitoring Assays with Ready-to-Use Reagents		Additional Therapeutic Drug Monitoring Assays
Acetaminophen Carbamazepine Digoxin Gentamicin N-Acetylprocainamide Phenobarbital Phenytoin Procainamide Quinidine Salicylic Acid Theophylline Tobramycin Valproic Acid Vancomycin		Amikacin Caffeine Disopyramide Ethosuximide Lidocaine Methotrexate Primidone Learn more
Learn more These products may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information.

How is Therapeutic Drug Monitoring Done? Testing is done using a clinical laboratory measurement of a chemical parameter which analyzes a blood sample collected into a test tube or vial. Effective testing can be completed on Beckman Coulter chemical analyzers AU480, AU680, AU5800 and DxC 700 AU with our comprehensive therapeutic drug monitoring menu to enhance your clinical laboratory.

BROCHURE
Therapeutic Drug Monitoring and Clinical Chemistry Systems

For some drugs, maintaining the therapeutic range can be difficult, because each person absorbs, metabolizes, utilizes and eliminates drugs differently. Learn more about the need for an effective therapeutic drug monitoring program.

Download

Address a Greater Demand

Meet the testing demands for therapeutic drug monitoring in your laboratory with a comprehensive menu of assays.

Explore now

Scalable Chemistry Solutions to Meet Any Workload

Consolidate testing and experience the flexibility to choose the right instrument and reagent combination to suit your laboratory's on-site requirements. Our comprehensive therapeutic drug monitoring and drugs-of-abuse menus run on the following Beckman Coulter Clinical Chemistry Analyzers:

Would you like more information on our therapeutic
drug monitoring solutions?
Let’s connect.

References:
SYVA® and EMIT® are registered trademarks of Siemens Healthcare Diagnostics.
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687654/
2. New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages. (2014, June 27). Harvard University: Edmond J. Safra Center for Ethics. https://ethics.harvard.edu/blog/new-prescription-drugs-major-health-risk-few-offsetting-advantages#:~:text=The European Commission estimates that, from prescription drugs each year
3. Centers for Disease Control and Prevention https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm
4. Therapeutic Drug Monitoring Market by Product, End-user, Drug Class, and Geography - Forecast and Analysis 2020-2024. https://www.technavio.com/
report/therapeutic-drug-monitoring-market-industry-analysis

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language

Country or Region

Language

Therapeutic Drug Monitoring

Costly. Deadly. Global.

Lack of therapeutic drug monitoring can lead to higher death rates, more adverse drug reactions and has proven costly to employers. And the numbers are staggering.

Menu Offering*